Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Radiation-induced bone loss is a serious problem for multiple myeloma survivors. Radiation can be effective at eliminating bone lesions. However, radiation can then cause bone loss having cause osteoclast formation to stop.
Radiation was effective at eliminating the lesions growing in my iliac crest. Terrific! Unfortunately, this therapy caused serious bone and nerve damage that would handicap me in the years following my conventional therapies.
As I often lament, “I wish I knew then what I know now.” Both PEMF and HBOT therapies would have prevented or dramatically reduced the damage caused by my radiation therapy.
Yes, there is evidence that Pulsed Electromagnetic Fields (PEMFs) can mitigate radiation-induced bone loss- Studies have shown that PEMFs can positively influence bone remodeling and help counteract bone density loss caused by radiation.
Bone health/strength is an ongoing pursuit of MM patents. MM itself can weaken your bones. Chemo, dexamethasone, etc. can weaken bones. And yes, radiation therapy weakens bone. A possible therapy then, can be PEMF.
Email me at David.PeopleBeatingCancer@gmail.com with questions about non-conventional bone health therapies.
Hang in there,
“Abstract- Radiotherapy increases tumor cure and survival rates; however, radiotherapy-induced bone damage remains a common issue for which effective countermeasures are lacking, especially considering tumor recurrence risks.
We report a high-specificity protection technique based on noninvasive electromagnetic field (EMF). A unique pulsed-burst EMF (PEMF) at 15 Hz and 2 mT induces notable Ca2+ oscillations with robust Ca2+ spikes in osteoblasts in contrast to other waveforms.
This waveform parameter substantially inhibits radiotherapy-induced bone loss by specifically modulating osteoblasts without affecting other bone cell types or tumor cells. Mechanistically, primary cilia are identified as major PEMF sensors in osteoblasts, and the differentiated ciliary expression dominates distinct PEMF sensitivity between osteoblasts and tumor cells.
PEMF-induced unique Ca2+ oscillations depend on interactions between ciliary polycystins-1/2 and endoplasmic reticulum, which activates the Ras/MAPK/AP-1 axis and subsequent DNA repair Ku70 transcription. Our study introduces a previously unidentified method against radiation-induced bone damage in a noninvasive, cost-effective, and highly specific manner…
DISCUSSION-
“The currently available anti-cancer therapies, such as gamma-radiation and chemotherapeutic agents, induce cell death and cellular senescence not only in cancer cells but also in the adjacent normal tissue. New anti-tumor approaches focus on limiting the side effects on normal cells…
In conclusion, PEMF irradiation is a promising pre-conditioning, non-invasive strategy for tumor elimination, limiting the side effects of traditional radiotherapy (Figure 6A), as revealed by our findings. PEMF-treated cancer cells not only displayed cell death but also senescence. In contrast, normal fibroblasts were not affected by the possible harmful effects of PEMFs, but increased their cellular viability (Figure 3C). These findings suggested that PEMFs reduced the viability of cancer cells without having side effects on the adjacent normal tissue (Figure 6B), an outcome that is observed during traditional radiation therapy…”
myeloma PEMF radiation bone loss myeloma PEMF radiation bone loss